Concepedia

Keguan Chen

KC

Statistics

Publications

4

Citations

188

H-Index

4

Active since

2002

Affiliations

GlaxoSmithKline (United States)(Current)

Age UK

GlaxoSmithKline (United Kingdom)

Keguan Chen is an author at GlaxoSmithKline (United States) specializing in antibody biology, antibody engineering, and allergy.

Top concepts

Publications per year

2002–2018

4

Publications

4

Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF‐I and EGF

Christina A. LeBedis, Keguan Chen, Lucia Fallavollita et al. · International Journal of Cancer · 2002 · 84 citations · Full text

Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study

Joanne Ellis, André van Maurik, Léa Fortunato et al. · British Journal of Clinical Pharmacology · 2018 · 42 citations · Full text

False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay

Keguan Chen, Jerry G. Page, Ann Schwartz et al. · Journal of Immunological Methods · 2013 · 33 citations

, , +10

A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of<sup>18</sup>F-FB-A20FMDV2 for Imaging the Integrin α<sub>v</sub>β<sub>6</sub>

Nicholas Keat, Julia Kenny, Keguan Chen et al. · Journal of Nuclear Medicine Technology · 2018 · 29 citations · Full text

1–4 of 4